Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6

NCT01433887 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

535

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: 48-weeks course
DRUG: Ribavirin
DRUG: Peginterferon alfa2a
DRUG: Ribavirin

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University